Salvatore De Vita Selected Research

Salvatore De Vita Research Topics

Disease

24	Rheumatoid Arthritis 01/2022 - 05/2006
24	Lymphoma (Lymphomas) 01/2022 - 01/2002
15	Infections 01/2022 - 09/2007
12	Cryoglobulinemia 01/2021 - 08/2002
11	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 05/2003
10	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2020 - 11/2004
9	Vasculitis (Vasculitides) 05/2019 - 05/2003
8	Arthritis (Polyarthritis) 01/2022 - 05/2006
8	Rheumatic Diseases (Rheumatism) 01/2021 - 08/2006
8	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 07/2020 - 01/2002
7	B-Cell Lymphoma (Lymphoma, B Cell) 05/2019 - 05/2003
6	COVID-19 01/2022 - 01/2020
6	Lymphadenopathy 01/2020 - 01/2017
6	Inflammation (Inflammations) 01/2020 - 12/2002
5	Sjogren's Syndrome (Sjogren Syndrome) 01/2022 - 08/2015
5	Purpura 01/2021 - 05/2003
4	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 08/2021 - 01/2009
4	Adult-Onset Still's Disease 01/2020 - 04/2007
3	Pneumonia (Pneumonitis) 01/2022 - 01/2020
3	Neoplasms (Cancer) 08/2021 - 04/2008
3	Leukopenia 01/2021 - 06/2014
3	Skin Ulcer 08/2019 - 06/2011
3	Peripheral Nervous System Diseases (PNS Diseases) 08/2019 - 05/2003
3	Non-Hodgkin Lymphoma (Lymphosarcoma) 05/2019 - 05/2006
3	Sialadenitis 05/2019 - 10/2007
3	Fatigue 01/2019 - 03/2015
3	Thrombocytopenia (Thrombopenia) 11/2017 - 05/2003
3	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 07/2014 - 10/2007
3	Systemic Vasculitis 12/2008 - 09/2007
2	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2022 - 01/2019
2	Proteinuria 11/2021 - 01/2018
2	Cytokine Release Syndrome 11/2020 - 01/2020
2	Hypergammaglobulinemia (Hyperimmunoglobulinemia) 01/2020 - 11/2015
2	Giant Cell Arteritis (Horton Disease) 01/2020 - 09/2012
2	Glomerulonephritis 08/2019 - 06/2011
2	Necrosis 01/2019 - 12/2007
2	Splenomegaly 01/2019 - 03/2017
2	Lymphopenia (Lymphocytopenia) 01/2019 - 12/2013
2	Pain (Aches) 01/2019 - 03/2015
2	Dry Eye Syndromes (Dry Eye Syndrome) 01/2019 - 12/2002
2	Neutropenia 01/2019 - 05/2003
2	Arthralgia (Joint Pain) 03/2017 - 05/2003
2	Virus Diseases (Viral Diseases) 12/2008 - 12/2002
2	Disease Progression 05/2006 - 01/2005
1	Appendicitis 01/2022
1	Abscess 01/2022
1	Gastroenteritis 01/2022
1	Lupus Nephritis 11/2021
1	Back Pain (Backache) 11/2021
1	Hypertension (High Blood Pressure) 11/2021

Drug/Important Bio-Agent (IBA)

25	Rituximab (Mabthera)FDA Link 01/2022 - 08/2002
20	Biological ProductsIBA 07/2021 - 12/2002
9	Rheumatoid FactorIBA 07/2020 - 03/2005
8	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2008
8	belimumabIBA 01/2022 - 07/2014
8	AntibodiesIBA 08/2020 - 05/2003
8	CryoglobulinsIBA 03/2017 - 03/2005
6	B-Cell Activating FactorIBA 02/2013 - 04/2004
5	AutoantibodiesIBA 01/2021 - 12/2007
4	Adalimumab (Humira)FDA Link 01/2022 - 05/2013
4	Methotrexate (Mexate)FDA LinkGeneric 07/2021 - 05/2006
4	CytokinesIBA 01/2021 - 12/2013
4	Interleukin-6 (Interleukin 6)IBA 11/2020 - 08/2006
4	Antiviral Agents (Antivirals)IBA 01/2016 - 12/2008
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 08/2021 - 03/2007
3	Tumor Necrosis Factor InhibitorsIBA 01/2021 - 01/2013
3	Antirheumatic Agents (DMARD)IBA 01/2021 - 08/2014
3	Immunoglobulins (Immunoglobulin)IBA 01/2021 - 01/2019
3	SteroidsIBA 01/2021 - 01/2019
3	tocilizumab (atlizumab)FDA Link 11/2020 - 05/2013
3	EnzymesIBA 12/2019 - 01/2013
3	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2019 - 05/2006
3	Anti-Citrullinated Protein AntibodiesIBA 11/2011 - 12/2009
2	Messenger RNA (mRNA)IBA 01/2022 - 10/2015
2	Pharmaceutical PreparationsIBA 01/2021 - 01/2020
2	Thymic Stromal LymphopoietinIBA 07/2020 - 05/2019
2	Interleukin-1 (Interleukin 1)IBA 02/2020 - 01/2020
2	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2020 - 09/2007
2	GlucocorticoidsIBA 01/2020 - 09/2012
2	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2020 - 01/2019
2	Hormones (Hormone)IBA 12/2019 - 01/2019
2	InterleukinsIBA 01/2014 - 08/2006
2	Immunoglobulin A (IgA)IBA 11/2010 - 09/2009
2	LigandsIBA 09/2009 - 04/2008
2	Monoclonal AntibodiesIBA 01/2009 - 08/2006
2	Antigen-Antibody Complex (Immune Complex)IBA 12/2008 - 09/2007
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2006 - 05/2006
1	Lysosomal Membrane ProteinsIBA 01/2022
1	upadacitinibIBA 01/2022
1	Annexin A5IBA 01/2022
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 01/2022
1	guselkumabIBA 01/2022
1	Propidium (Propidium Iodide)IBA 01/2022
1	Cell Adhesion MoleculesIBA 01/2022
1	Caspase 3 (Caspase-3)IBA 01/2022
1	ianalumabIBA 01/2022
1	CreatinineIBA 11/2021

Therapy/Procedure

24	Therapeutics 01/2022 - 05/2003
2	Retreatment 09/2015 - 07/2015
2	Drug Therapy (Chemotherapy) 01/2005 - 04/2004